Special blood storage could cut transfusions for cancer patients

NCT ID NCT06685848

Ongoing Disease control Sponsor: Hemanext Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study tests whether red blood cells stored with less oxygen (hypoxic RBCs) are safer and more effective than standard transfusions for people with blood cancers who need regular blood. About 24 adults with transfusion-dependent blood cancers will receive both types of blood in a random order. The goal is to see if the special cells reduce the number of transfusions needed over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm Hypoxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOLOGIC NEOPLASMS

Contacts and locations

Locations

Duke University Health System

Durham, North Carolina, 27705, United States
Haukeland University Hospital

Bergen, 5021, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.